Dimensional Fund Advisors’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,240,500
| Closed | -$40.7M | – | 3585 |
|
|
2022
Q2 | $40.7M | Sell |
1,240,500
-158,192
| -11% | -$5M | 0.01% | 1443 |
|
|
2022
Q1 | $36.8M | Buy |
1,398,692
+81,995
| +6% | +$2M | 0.01% | 1624 |
|
|
2021
Q4 | $31.2M | Buy |
1,316,697
+12,655
| +1% | +$312K | 0.01% | 1734 |
|
|
2021
Q3 | $32.7M | Buy |
1,304,042
+2,016
| +0.2% | +$51.4K | 0.01% | 1731 |
|
|
2021
Q2 | $33.8M | Buy |
1,302,026
+101,411
| +8% | +$2.76M | 0.01% | 1742 |
|
|
2021
Q1 | $30.8M | Sell |
1,200,615
-35,548
| -3% | -$911K | 0.01% | 1785 |
|
|
2020
Q4 | $24.8M | Sell |
1,236,163
-19,992
| -2% | -$392K | 0.01% | 1867 |
|
|
2020
Q3 | $21.5M | Sell |
1,256,155
-35,877
| -3% | -$678K | 0.01% | 1809 |
|
|
2020
Q2 | $28.2M | Sell |
1,292,032
-168,682
| -12% | -$3.86M | 0.01% | 1656 |
|
|
2020
Q1 | $33.8M | Sell |
1,460,714
-69,381
| -5% | -$2.02M | 0.02% | 1373 |
|
|
2019
Q4 | $50.5M | Sell |
1,530,095
-21,542
| -1% | -$690K | 0.02% | 1420 |
|
|
2019
Q3 | $49.4M | Sell |
1,551,637
-6,527
| -0.4% | -$190K | 0.02% | 1394 |
|
|
2019
Q2 | $40M | Sell |
1,558,164
-52,468
| -3% | -$1.34M | 0.02% | 1614 |
|
|
2019
Q1 | $40.9M | Buy |
1,610,632
+14,575
| +0.9% | +$435K | 0.02% | 1601 |
|
|
2018
Q4 | $54.3M | Sell |
1,596,057
-17,465
| -1% | -$568K | 0.02% | 1141 |
|
|
2018
Q3 | $57.5M | Sell |
1,613,522
-1,895
| -0.1% | -$66.9K | 0.02% | 1312 |
|
|
2018
Q2 | $55.7M | Buy |
1,615,417
+2,228
| +0.1% | +$78.1K | 0.02% | 1304 |
|
|
2018
Q1 | $54.3M | Sell |
1,613,189
-6,148
| -0.4% | -$195K | 0.02% | 1244 |
|
|
2017
Q4 | $61.9M | Buy |
1,619,337
+14,461
| +0.9% | +$577K | 0.03% | 1104 |
|
|
2017
Q3 | $60.2M | Buy |
1,604,876
+51,938
| +3% | +$1.83M | 0.03% | 1086 |
|
|
2017
Q2 | $57.9M | Buy |
1,552,938
+151,372
| +11% | +$5.47M | 0.03% | 1058 |
|
|
2017
Q1 | $55M | Buy |
1,401,566
+38,125
| +3% | +$1.43M | 0.03% | 1081 |
|
|
2016
Q4 | $47.4M | Buy |
1,363,441
+29,472
| +2% | +$1.16M | 0.02% | 1184 |
|
|
2016
Q3 | $52.4M | Sell |
1,333,969
-4,036
| -0.3% | -$161K | 0.03% | 981 |
|
|
2016
Q2 | $50.6M | Sell |
1,338,005
-68,646
| -5% | -$2.3M | 0.03% | 960 |
|
|
2016
Q1 | $54.1M | Sell |
1,406,651
-54,398
| -4% | -$2.03M | 0.03% | 831 |
|
|
2015
Q4 | $70.2M | Sell |
1,461,049
-23,165
| -2% | -$1.07M | 0.04% | 571 |
|
|
2015
Q3 | $58.6M | Sell |
1,484,214
-24,935
| -2% | -$1.06M | 0.04% | 658 |
|
|
2015
Q2 | $64.2M | Sell |
1,509,149
-96,241
| -6% | -$3.84M | 0.04% | 648 |
|
|
2015
Q1 | $63.4M | Buy |
1,605,390
+49,876
| +3% | +$1.84M | 0.04% | 625 |
|
|
2014
Q4 | $56.1M | Buy |
1,555,514
+35,537
| +2% | +$1.19M | 0.04% | 661 |
|
|
2014
Q3 | $44.9M | Sell |
1,519,977
-20,740
| -1% | -$572K | 0.03% | 779 |
|
|
2014
Q2 | $38.7M | Buy |
1,540,717
+101,480
| +7% | +$2.51M | 0.03% | 944 |
|
|
2014
Q1 | $37.1M | Buy |
1,439,237
+45,981
| +3% | +$1.16M | 0.03% | 906 |
|
|
2013
Q4 | $31.3M | Buy |
1,393,256
+80,894
| +6% | +$1.56M | 0.02% | 1023 |
|
|
2013
Q3 | $18.6M | Buy |
1,312,362
+82,018
| +7% | +$1.1M | 0.02% | 1501 |
|
|
2013
Q2 | $16.8M | Buy |
+1,230,344
| New | +$16.8M | 0.02% | 1493 |
|
Other funds holding NTUS
Dimensional Fund Advisors's NTUS Position: Q3 2022 in Review
Dimensional Fund Advisors sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 1,240,500 shares — an estimated $40.7M sold.
Dimensional Fund Advisors first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $70.2M in Q4 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Dimensional Fund Advisors reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,240,500 Natus Medical Inc shares in Q3 2022, an estimated $40.7M.
- Dimensional Fund Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Dimensional Fund Advisors's Natus Medical Inc position peaked at $70.2M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.